News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
38,305 Results
Type
Article (2555)
Company Profile (39)
Press Release (35711)
Section
Business (14594)
Career Advice (76)
Deals (2234)
Drug Delivery (7)
Drug Development (4219)
Employer Resources (10)
FDA (514)
Job Trends (819)
News (20892)
Policy (1126)
Tag
Academia (153)
Africa (44)
Alliances (3521)
Alzheimer's disease (40)
Antibody-drug conjugate (ADC) (5)
Approvals (511)
Arizona (13)
Asia (2005)
Australia (300)
Bankruptcy (12)
Best Places to Work (523)
Biosimilars (9)
Biotechnology (31)
C2C Services and Suppliers (2071)
California (287)
Canada (55)
Cancer (29)
Career advice (64)
Cell therapy (9)
China (11)
Clinical research (3115)
Collaboration (19)
Colorado (6)
Compensation (10)
Connecticut (7)
COVID-19 (179)
CRISPR (5)
C-suite (5)
Cystic fibrosis (7)
Data (12)
Diagnostics (463)
Earnings (4187)
Employer resources (8)
Europe (3874)
Events (5861)
Executive appointments (17)
FDA (518)
Florida (12)
Funding (17)
Gene editing (8)
Gene therapy (7)
GLP-1 (48)
Government (166)
Healthcare (728)
Hotbed/Location (28312)
Illinois (11)
Indiana (14)
Infectious disease (179)
Inflammatory bowel disease (10)
Interviews (7)
IPO (1062)
Job creations (294)
Job search strategy (62)
Kansas (12)
Layoffs (32)
Legal (213)
Liver cancer (6)
Lung cancer (7)
Manufacturing (5)
Maryland (11)
Massachusetts (89)
Medical device (312)
Medtech (312)
Mergers & acquisitions (1177)
Metabolic disorders (10)
Minnesota (8)
Neuroscience (53)
New Jersey (9)
New York (17)
NextGen Class of 2024 (385)
Non-profit (176)
North Carolina (58)
Northern California (127)
Ohio (17)
Opinion (14)
Patents (9)
Pennsylvania (14)
People (5638)
Phase I (1330)
Phase II (1563)
Phase III (848)
Pipeline (7)
Policy (7)
Postmarket research (34)
Preclinical (588)
Radiopharmaceuticals (11)
Rare diseases (9)
Real estate (425)
Recruiting (5)
Regulatory (815)
Research institute (146)
Resumes & cover letters (9)
Schizophrenia (5)
South America (40)
Southern California (137)
Startups (569)
Texas (11)
United States (617)
Vaccines (18)
Washington State (10)
Date
Today (5)
Last 7 days (35)
Last 30 days (175)
Last 365 days (2896)
2024 (2044)
2023 (2968)
2022 (3890)
2021 (4262)
2020 (3730)
2019 (2195)
2018 (1654)
2017 (1887)
2016 (1665)
2015 (1903)
2014 (1418)
2013 (1226)
2012 (1425)
2011 (1358)
2010 (1209)
38,305 Results for "orbis biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Orbis International and NIDEK Join Forces to Scale Up Artificial Intelligence Eye Screenings in Vietnam
Orbis International announces an important in-kind and financial donation from NIDEK to support Orbis’s artificial intelligence -based screening services in Vietnam.
January 16, 2024
·
4 min read
Policy
Agitated Solutions Receives Health Canada License for Orbis Microbubble Generator to Streamline Cardiac Bubble Studies
Agitated Solutions, Incorporated announced that it has been issued a Medical Device Establishment License from Health Canada for its innovative Orbis™ Microbubble Generator that simplifies and streamlines the process of saline agitation and delivery for cardiac bubble studies.
April 18, 2024
·
3 min read
Business
Novo Holdings, Forbion Lead Financing for Orbis Medicine’s $28M Seed Round
Denmark-based startup Orbis Medicines has launched with €26 million in seed funding in its drive to search for macrocycle drugs, with a focus on high-value oral alternatives to blockbuster biologics.
February 29, 2024
·
2 min read
·
Tyler Patchen
Orbis Medicines Launches with €26 Million Seed Financing to Transform Macrocycle Drug Development through Next-Generation Orally Dosable ‘nCycles’
Orbis Medicines, a leader in oral macrocycle drug discovery, announces its launch with a €26 million financing led by global life sciences investor Novo Holdings and European life sciences venture firm Forbion.
February 29, 2024
·
6 min read
Business
Orbis International Teams Up with the Alcon Foundation and OMEGA to Improve Eye Care in Zambia
Global eye care nonprofit, Orbis International, is kicking off a surgical training program in Zambia on board the Orbis Flying Eye Hospital - the world’s only fully accredited ophthalmic teaching hospital on board a plane.
September 25, 2023
·
7 min read
Layoffs
Aadi Bioscience to Lay Off 80% of R&D Staff
Aadi Bioscience expects that pipeline adjustments and the workforce reduction will extend its cash runway into at least the second half of 2026.
August 21, 2024
·
1 min read
·
Angela Gabriel
Business
MBX Biosciences Appoints Salomon Azoulay, M.D., as Chief Medical Officer
MBX Biosciences, Inc. today announced the appointment of Salomon (Sam) Azoulay, M.D, as Chief Medical Officer (CMO).
June 25, 2024
·
3 min read
Press Releases
Precision BioSciences Announces its Addition to the Russell Microcap® Index
Precision BioSciences, Inc. today announced its addition to the Russell Microcap® Index.
July 1, 2024
·
9 min read
Drug Development
Genflow Biosciences PLC Announces Strengthening of Pre-Clinical Efforts
Genflow Biosciences Strengthens Pre-Clinical Efforts with FDA Guidance and CDMO and CRO Selection
June 27, 2024
·
6 min read
Marvel Biosciences Announces Private Placement Update
Marvel Biosciences Corp. (TSXV: MRVL) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the “Company” or “Marvel”), wishes to announce that
June 21, 2024
·
2 min read
1 of 3,831
Next
